Nontuberculous Mycobacteria (NTM), Bronchiectasis and COVID-19: Research and Treatment Update

Nontuberculous mycobacteria (NTM), a non-contagious cousin of tuberculosis, is showing a marked increase in the U.S. population in recent years. Many of these patients also end up developing bronchiectasis, a condition that inhibits the ability to naturally clear mucous and bacteria from the airways and puts individuals at ever-increasing risk of infection. Find out how COVID-19 is impacting these patients and learn about current and future NTM and bronchiectasis research and treatments. To sign up for future Dialogue with a Doc discussions, please visit


Related Videos

Want to use this on your website? Fill out the content usage request form and then copy this code: